1 | 18 FDG | - | - | - | - | [1] 145 145 |
2 | Acetate | [1] Acetate Acetate | - | - | - | [43] 1 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299 |
3 | ACTH | [1] Corticotropin Corticotropin | [1] D00146
D00146
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [5] 13 13, 66, 145, 193, 222 |
4 | Adrenocorticotropin hormone | - | - | - | - | [1] 145 145 |
5 | AMZ002 | - | - | - | - | [1] 145 145 |
6 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [18] 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
7 | Cannabidiol (CBD) | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [7] 6 6, 13, 140, 144, 145, 156, 158 |
8 | Cannabidiol Oral Solution | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 140 140, 144, 145, 193 |
9 | CBD | - | - | - | - | [12] 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
10 | Combination therapy with vigabatrin and prednisolone | [2] Prednisolone Prednisolone, Vigabatrin | [9] D00472
D00472
,
D00535
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [2] ABAT ABAT, NR3C1 💬 | [8] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
11 | Cosyntropin | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 83 83, 113, 145 |
12 | Cosyntropin Injectable Suspension 1 MG/ML + vigabatrin | [2] Tetracosactide Tetracosactide, Vigabatrin | [2] D00284
D00284
,
D00535
| [2] ABAT ABAT, MC2R 💬 | [12] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Aldosterone synthesis and secretion, Butanoate metabolism, Cortisol synthesis and secretion, Cushing syndrome, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism, cAMP signaling pathway 💬 | [1] 145 145 |
13 | Cosyntropin Injectable Suspension, 1 mg/mL | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [1] 145 145 |
14 | Decortin H | - | - | - | - | [3] 66 66, 97, 145 |
15 | FENFLURAMINE | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 140 140, 144, 145, 149 |
16 | Ganaxolone | [1] Ganaxolone Ganaxolone | [1] D04300
D04300
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [4] 145 145, 152, 158, 206 |
17 | GWP42003-P | - | - | - | - | [5] 140 140, 144, 145, 156, 158 |
18 | Intravenous Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 13 13, 145 |
19 | JBPOS0101 | [1] JBPOS0101 JBPOS0101 | - | - | - | [1] 145 145 |
20 | Ketogenic diet | - | - | - | - | [2] 145 145, 230 |
21 | M071754 | - | - | - | - | [1] 145 145 |
22 | Melatonin | [1] Melatonin Melatonin | [1] D08170
D08170
| [2] MTNR1A MTNR1A, MTNR1B 💬 | [2] Circadian entrainment Circadian entrainment, Neuroactive ligand-receptor interaction 💬 | [12] 6 6, 8, 13, 37, 46, 49, 90, 97, 144, 145, 149, 202 |
23 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [6] D00407
D00407
,
D00751
,
D00979
,
D05000
,
D05001
,
D05002
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [48] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300 |
24 | Modified Atkins diet | - | - | - | - | [3] 145 145, 157, 187 |
25 | Null | - | - | - | - | [16] 6 6, 13, 15, 28, 37, 46, 49, 51, 63, 86, 90, 96, 97, 107, 145, 271 |
26 | Oral Pednisolone | - | - | - | - | [1] 145 145 |
27 | Oral prednisolone | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [3] 49 49, 96, 145 |
28 | Other: modified Atkins diet | - | - | - | - | [1] 145 145 |
29 | PREDNISOLONE | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [43] 3 3, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300, 307 |
30 | PYRIDOXINE | [1] Pyridoxine Pyridoxine | [2] D02179
D02179
,
D08454
| - | - | [3] 93 93, 145, 320 |
31 | Pyridoxine plus prednisolone | [2] Prednisolone Prednisolone, Pyridoxine | [10] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D02179
,
D03301
,
D08454
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 |
32 | Radiprodil | [1] Radiprodil Radiprodil | - | - | - | [1] 145 145 |
33 | SABRIL | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 145 145, 158 |
34 | Sabril granules for oral use | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
35 | SABRIL SACHETS | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
36 | Sabrilex | - | - | - | - | [1] 145 145 |
37 | Sabril® | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
38 | SOLUBLE PREDNISOLONE TABLETS | [1] Prednisolone Prednisolone | [8] D00472
D00472
,
D00980
,
D00981
,
D00982
,
D01239
,
D01998
,
D02156
,
D03301
| [1] NR3C1 NR3C1 💬 | [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [1] 145 145 |
39 | SPT3162 | - | - | - | - | [1] 145 145 |
40 | Synacthen Depot | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [3] 83 83, 145, 222 |
41 | Tetracosactide | [1] Tetracosactide Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [4] 83 83, 113, 145, 222 |
42 | Tetracosactide acetate | [2] Acetate Acetate, Tetracosactide | [1] D00284
D00284
| [1] MC2R MC2R 💬 | [5] Aldosterone synthesis and secretion Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬 | [2] 83 83, 145 |
43 | Tricaprilin | [1] Tricaprylin Tricaprylin | - | - | - | [1] 145 145 |
44 | UCB3491 | - | - | - | - | [1] 145 145 |
45 | VGB-ST | - | - | - | - | [1] 145 145 |
46 | VGB-ST soluble tablets | - | - | - | - | [1] 145 145 |
47 | VIGABATRIN | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [2] 145 145, 158 |
48 | Vigabatrin Tablets | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
49 | Vigabatrin: Vigabatrin new ST formulation then Sabril® | [1] Vigabatrin Vigabatrin | [1] D00535
D00535
| [1] ABAT ABAT 💬 | [7] Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 | [1] 145 145 |
50 | Vitamin B1 | [1] Thiamine Thiamine | [1] D08580
D08580
| - | - | [1] 145 145 |